Highlights
NASDAQ: ACOR       Acorda Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
2.14   +0.03 (1.42%)  2.11 - 2.20  1,004,081

Overview

 
Avg Volume (4 weeks):3,905,011
4 Weeks Range:1.815 - 2.77
4 Weeks Price Volatility (%):
34.03%
52 Weeks Range:1.49 - 17.41
52 Weeks Price Volatility (%):
4.08%
Average Price Target: 42.00
Price Target Upside/Downside: +39.86

Headlines



No recent Headlines for this stock.


Business Background

Acorda Therapeutics is a biotechnology company that identifies, develops, and commercializes novel therapies for neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson’s disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

  Be the first to like this.
 


 

2266  3296  438  2964 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 12.90+1.17 
 ACHN 6.760.00 
 AMD 46.75-3.78 
 AVP 5.60-0.05 
 CHK 0.56+0.041 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 AAPL 327.086+9.396 
Partners & Brokers